nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS3—hindlimb—amyotrophic lateral sclerosis	0.0414	0.0936	CbGeAlD
L-Arginine—NOS3—appendage—amyotrophic lateral sclerosis	0.0355	0.0803	CbGeAlD
L-Arginine—ARG2—hindbrain—amyotrophic lateral sclerosis	0.027	0.061	CbGeAlD
L-Arginine—AZIN2—medulla oblongata—amyotrophic lateral sclerosis	0.0207	0.0468	CbGeAlD
L-Arginine—AZIN2—spinal cord—amyotrophic lateral sclerosis	0.0185	0.0417	CbGeAlD
L-Arginine—SLC7A1—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.0165	0.0327	CbGpPWpGaD
L-Arginine—SLC7A4—nervous system—amyotrophic lateral sclerosis	0.0162	0.0367	CbGeAlD
L-Arginine—SLC7A4—central nervous system—amyotrophic lateral sclerosis	0.0156	0.0353	CbGeAlD
L-Arginine—ARG2—brainstem—amyotrophic lateral sclerosis	0.0155	0.035	CbGeAlD
L-Arginine—SLC7A3—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.0154	0.0304	CbGpPWpGaD
L-Arginine—AZIN2—cerebellum—amyotrophic lateral sclerosis	0.0146	0.0331	CbGeAlD
L-Arginine—ASL—nervous system—amyotrophic lateral sclerosis	0.0145	0.0327	CbGeAlD
L-Arginine—AZIN2—Amino acid and derivative metabolism—DAO—amyotrophic lateral sclerosis	0.0142	0.028	CbGpPWpGaD
L-Arginine—SLC7A1—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.0141	0.0278	CbGpPWpGaD
L-Arginine—ASL—central nervous system—amyotrophic lateral sclerosis	0.0139	0.0315	CbGeAlD
L-Arginine—ASL—cerebellum—amyotrophic lateral sclerosis	0.0136	0.0308	CbGeAlD
L-Arginine—SLC7A3—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.0131	0.0258	CbGpPWpGaD
L-Arginine—ASL—Amino acid and derivative metabolism—DAO—amyotrophic lateral sclerosis	0.013	0.0256	CbGpPWpGaD
L-Arginine—SLC7A4—brain—amyotrophic lateral sclerosis	0.0124	0.028	CbGeAlD
L-Arginine—AZIN2—brain—amyotrophic lateral sclerosis	0.0119	0.0269	CbGeAlD
L-Arginine—Paraesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.0118	0.226	CcSEcCtD
L-Arginine—NOS3—Endothelin Pathways—ECE1—amyotrophic lateral sclerosis	0.0116	0.023	CbGpPWpGaD
L-Arginine—ASL—brain—amyotrophic lateral sclerosis	0.0111	0.025	CbGeAlD
L-Arginine—NOS2—Spinal Cord Injury—PTPRZ1—amyotrophic lateral sclerosis	0.011	0.0219	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—RAB5A—amyotrophic lateral sclerosis	0.0108	0.0214	CbGpPWpGaD
L-Arginine—ARG2—medulla oblongata—amyotrophic lateral sclerosis	0.0108	0.0244	CbGeAlD
L-Arginine—ARG2—Amino acid and derivative metabolism—DAO—amyotrophic lateral sclerosis	0.0107	0.0212	CbGpPWpGaD
L-Arginine—SLC7A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00973	0.0193	CbGpPWpGaD
L-Arginine—ARG2—spinal cord—amyotrophic lateral sclerosis	0.00962	0.0218	CbGeAlD
L-Arginine—SLC7A1—nervous system—amyotrophic lateral sclerosis	0.00948	0.0214	CbGeAlD
L-Arginine—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.00929	0.178	CcSEcCtD
L-Arginine—SLC7A1—central nervous system—amyotrophic lateral sclerosis	0.00913	0.0206	CbGeAlD
L-Arginine—SLC7A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00905	0.0179	CbGpPWpGaD
L-Arginine—SLC7A1—cerebellum—amyotrophic lateral sclerosis	0.00892	0.0202	CbGeAlD
L-Arginine—SLC7A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00827	0.0164	CbGpPWpGaD
L-Arginine—ARG2—nervous system—amyotrophic lateral sclerosis	0.00811	0.0183	CbGeAlD
L-Arginine—ARG2—central nervous system—amyotrophic lateral sclerosis	0.00781	0.0176	CbGeAlD
L-Arginine—SLC7A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00769	0.0152	CbGpPWpGaD
L-Arginine—ARG2—cerebellum—amyotrophic lateral sclerosis	0.00763	0.0172	CbGeAlD
L-Arginine—ASS1—medulla oblongata—amyotrophic lateral sclerosis	0.00756	0.0171	CbGeAlD
L-Arginine—ASS1—Amino acid and derivative metabolism—DAO—amyotrophic lateral sclerosis	0.00744	0.0147	CbGpPWpGaD
L-Arginine—SLC7A1—brain—amyotrophic lateral sclerosis	0.00725	0.0164	CbGeAlD
L-Arginine—NOS2—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00721	0.0143	CbGpPWpGaD
L-Arginine—SLC16A10—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.00708	0.014	CbGpPWpGaD
L-Arginine—ASS1—spinal cord—amyotrophic lateral sclerosis	0.00674	0.0152	CbGeAlD
L-Arginine—ARG2—brain—amyotrophic lateral sclerosis	0.0062	0.014	CbGeAlD
L-Arginine—SLC16A10—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.00602	0.0119	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—ATF1—amyotrophic lateral sclerosis	0.00592	0.0117	CbGpPWpGaD
L-Arginine—ASS1—nervous system—amyotrophic lateral sclerosis	0.00568	0.0128	CbGeAlD
L-Arginine—NOS3—nervous system—amyotrophic lateral sclerosis	0.00566	0.0128	CbGeAlD
L-Arginine—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00549	0.105	CcSEcCtD
L-Arginine—ASS1—central nervous system—amyotrophic lateral sclerosis	0.00547	0.0124	CbGeAlD
L-Arginine—NOS3—central nervous system—amyotrophic lateral sclerosis	0.00545	0.0123	CbGeAlD
L-Arginine—ASS1—cerebellum—amyotrophic lateral sclerosis	0.00535	0.0121	CbGeAlD
L-Arginine—NOS3—Corticotropin-releasing hormone—CASP12—amyotrophic lateral sclerosis	0.00511	0.0101	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—ECE1—amyotrophic lateral sclerosis	0.00511	0.0101	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—amyotrophic lateral sclerosis	0.00454	0.00898	CbGpPWpGaD
L-Arginine—SLC7A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00435	0.0086	CbGpPWpGaD
L-Arginine—ASS1—brain—amyotrophic lateral sclerosis	0.00434	0.00982	CbGeAlD
L-Arginine—NOS3—brain—amyotrophic lateral sclerosis	0.00433	0.00979	CbGeAlD
L-Arginine—NOS2—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	0.00431	0.00853	CbGpPWpGaD
L-Arginine—SLC22A4—spinal cord—amyotrophic lateral sclerosis	0.00429	0.0097	CbGeAlD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—ATXN2—amyotrophic lateral sclerosis	0.00429	0.00849	CbGpPWpGaD
L-Arginine—SLC16A10—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00417	0.00824	CbGpPWpGaD
L-Arginine—SLC7A3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00404	0.008	CbGpPWpGaD
L-Arginine—SLC16A10—cerebellum—amyotrophic lateral sclerosis	0.00382	0.00864	CbGeAlD
L-Arginine—SLC7A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.0037	0.00732	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.0036	0.00711	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.0036	0.00711	CbGpPWpGaD
L-Arginine—SLC16A10—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00354	0.00701	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.00352	0.00696	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.00348	0.00688	CbGpPWpGaD
L-Arginine—SLC7A3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00344	0.0068	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00343	0.00678	CbGpPWpGaD
L-Arginine—SLC22A4—cerebellum—amyotrophic lateral sclerosis	0.0034	0.00769	CbGeAlD
L-Arginine—NOS2—AGE/RAGE pathway—CASP9—amyotrophic lateral sclerosis	0.0034	0.00672	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—CASP9—amyotrophic lateral sclerosis	0.00336	0.00664	CbGpPWpGaD
L-Arginine—SLC7A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.0033	0.00652	CbGpPWpGaD
L-Arginine—ASL—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00329	0.00651	CbGpPWpGaD
L-Arginine—ASL—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00329	0.00651	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00329	0.00651	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00319	0.00631	CbGpPWpGaD
L-Arginine—SLC22A5—medulla oblongata—amyotrophic lateral sclerosis	0.00318	0.0072	CbGeAlD
L-Arginine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00316	0.00625	CbGpPWpGaD
L-Arginine—SLC7A3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00306	0.00606	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00306	0.00605	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—SOD1—amyotrophic lateral sclerosis	0.00305	0.00603	CbGpPWpGaD
L-Arginine—ASL—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00301	0.00595	CbGpPWpGaD
L-Arginine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00296	0.0567	CcSEcCtD
L-Arginine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00295	0.0564	CcSEcCtD
L-Arginine—AZIN2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00287	0.00569	CbGpPWpGaD
L-Arginine—SLC22A5—spinal cord—amyotrophic lateral sclerosis	0.00284	0.00642	CbGeAlD
L-Arginine—ASL—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.0028	0.00553	CbGpPWpGaD
L-Arginine—SLC22A4—brain—amyotrophic lateral sclerosis	0.00276	0.00625	CbGeAlD
L-Arginine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00276	0.0529	CcSEcCtD
L-Arginine—NOS2—AGE/RAGE pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00273	0.00541	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00273	0.00539	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00273	0.00539	CbGpPWpGaD
L-Arginine—NOS2—Alpha9 beta1 integrin signaling events—VEGFA—amyotrophic lateral sclerosis	0.00264	0.00522	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—CASP9—amyotrophic lateral sclerosis	0.00264	0.00522	CbGpPWpGaD
L-Arginine—ASL—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00263	0.0052	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—DAO—amyotrophic lateral sclerosis	0.0026	0.00514	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—PTGS2—amyotrophic lateral sclerosis	0.00256	0.00506	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00249	0.00493	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—BDNF—amyotrophic lateral sclerosis	0.00246	0.00488	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—RAB5A—amyotrophic lateral sclerosis	0.00246	0.00487	CbGpPWpGaD
L-Arginine—NOS2—Platelet homeostasis—PLA2G4A—amyotrophic lateral sclerosis	0.00239	0.00473	CbGpPWpGaD
L-Arginine—ASL—Metabolism—DAO—amyotrophic lateral sclerosis	0.00238	0.0047	CbGpPWpGaD
L-Arginine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00237	0.00469	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—SOD1—amyotrophic lateral sclerosis	0.00237	0.00468	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—MMP9—amyotrophic lateral sclerosis	0.00236	0.00466	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00232	0.00458	CbGpPWpGaD
L-Arginine—SLC22A5—cerebellum—amyotrophic lateral sclerosis	0.00225	0.00509	CbGeAlD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00221	0.00437	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00218	0.00431	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00212	0.0042	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—VEGFA—amyotrophic lateral sclerosis	0.00212	0.00419	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—IGF1—amyotrophic lateral sclerosis	0.00211	0.00418	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00205	0.00406	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—CASP9—amyotrophic lateral sclerosis	0.00202	0.004	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.00198	0.00392	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00197	0.0377	CcSEcCtD
L-Arginine—ARG2—Metabolism—DAO—amyotrophic lateral sclerosis	0.00197	0.0039	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00197	0.0039	CbGpPWpGaD
L-Arginine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00192	0.0368	CcSEcCtD
L-Arginine—NOS2—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.00192	0.00379	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00191	0.0365	CcSEcCtD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00189	0.00375	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00189	0.00374	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00189	0.00374	CbGpPWpGaD
L-Arginine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00188	0.036	CcSEcCtD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00188	0.00372	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00188	0.00372	CbGpPWpGaD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00186	0.00368	CbGpPWpGaD
L-Arginine—NOS3—Platelet homeostasis—PLA2G4A—amyotrophic lateral sclerosis	0.00186	0.00367	CbGpPWpGaD
L-Arginine—SLC22A5—brain—amyotrophic lateral sclerosis	0.00183	0.00413	CbGeAlD
L-Arginine—NOS3—VEGFR1 specific signals—VEGFA—amyotrophic lateral sclerosis	0.00182	0.0036	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—GSR—amyotrophic lateral sclerosis	0.00182	0.0036	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PLB1—amyotrophic lateral sclerosis	0.0018	0.00357	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.0018	0.00356	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00175	0.00346	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00175	0.00346	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00173	0.00342	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—IGFBP3—amyotrophic lateral sclerosis	0.00172	0.00341	CbGpPWpGaD
L-Arginine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0328	CcSEcCtD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00167	0.00331	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—amyotrophic lateral sclerosis	0.00167	0.0033	CbGpPWpGaD
L-Arginine—ASL—Metabolism—GSR—amyotrophic lateral sclerosis	0.00166	0.00329	CbGpPWpGaD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00161	0.00318	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00161	0.00318	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—IGF1—amyotrophic lateral sclerosis	0.0016	0.00316	CbGpPWpGaD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00158	0.00313	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00156	0.00308	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.00154	0.00304	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—MMP9—amyotrophic lateral sclerosis	0.00154	0.00304	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	0.00152	0.00301	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00151	0.00299	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00149	0.00295	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00149	0.00295	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00149	0.00295	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00147	0.00291	CbGpPWpGaD
L-Arginine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00145	0.0278	CcSEcCtD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00143	0.00284	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—CASP3—amyotrophic lateral sclerosis	0.00143	0.00283	CbGpPWpGaD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00142	0.00281	CbGpPWpGaD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00141	0.00279	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—ATF1—amyotrophic lateral sclerosis	0.0014	0.00277	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—GSR—amyotrophic lateral sclerosis	0.00138	0.00273	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00137	0.00271	CbGpPWpGaD
L-Arginine—ASL—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00137	0.0027	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—DAO—amyotrophic lateral sclerosis	0.00137	0.0027	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—MMP9—amyotrophic lateral sclerosis	0.00135	0.00267	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—ATF1—amyotrophic lateral sclerosis	0.00135	0.00267	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.00128	0.00252	CbGpPWpGaD
L-Arginine—NOS2—Disease—TPK1—amyotrophic lateral sclerosis	0.00126	0.0025	CbGpPWpGaD
L-Arginine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00125	0.024	CcSEcCtD
L-Arginine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00124	0.0238	CcSEcCtD
L-Arginine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00124	0.0238	CcSEcCtD
L-Arginine—NOS2—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00124	0.00244	CbGpPWpGaD
L-Arginine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00124	0.0236	CcSEcCtD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.00121	0.0024	CbGpPWpGaD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00121	0.00239	CbGpPWpGaD
L-Arginine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00117	0.0224	CcSEcCtD
L-Arginine—ARG2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00113	0.00224	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00112	0.00222	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—CASP3—amyotrophic lateral sclerosis	0.00111	0.0022	CbGpPWpGaD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00108	0.00213	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00107	0.00211	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—MMP9—amyotrophic lateral sclerosis	0.00105	0.00208	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—VEGFA—amyotrophic lateral sclerosis	0.00104	0.00207	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00104	0.00205	CbGpPWpGaD
L-Arginine—NOS2—Disease—VTA1—amyotrophic lateral sclerosis	0.00101	0.002	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.00099	0.00196	CbGpPWpGaD
L-Arginine—NOS3—Disease—TPK1—amyotrophic lateral sclerosis	0.000982	0.00194	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.000968	0.00191	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000962	0.0019	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000959	0.0019	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000955	0.00189	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000946	0.00187	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—amyotrophic lateral sclerosis	0.00092	0.00182	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—amyotrophic lateral sclerosis	0.000906	0.00179	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000898	0.00178	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—CASP3—amyotrophic lateral sclerosis	0.000851	0.00168	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.000849	0.00168	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000822	0.00163	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000822	0.00163	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000818	0.00162	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000818	0.00162	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000805	0.00159	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000805	0.00159	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000803	0.00159	CbGpPWpGaD
L-Arginine—NOS3—Disease—VTA1—amyotrophic lateral sclerosis	0.000785	0.00155	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000784	0.00155	CbGpPWpGaD
L-Arginine—NOS2—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000766	0.00152	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000752	0.00149	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000738	0.00146	CbGpPWpGaD
L-Arginine—ASL—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000734	0.00145	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000729	0.00144	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000723	0.00143	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000717	0.00142	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000699	0.00138	CbGpPWpGaD
L-Arginine—NOS2—Disease—PLB1—amyotrophic lateral sclerosis	0.000693	0.00137	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000675	0.00133	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000657	0.0013	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—VEGFA—amyotrophic lateral sclerosis	0.00064	0.00127	CbGpPWpGaD
L-Arginine—NOS2—Disease—VCP—amyotrophic lateral sclerosis	0.000618	0.00122	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000615	0.00122	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000615	0.00122	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000608	0.0012	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000607	0.0012	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—VEGFA—amyotrophic lateral sclerosis	0.000604	0.0012	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000597	0.00118	CbGpPWpGaD
L-Arginine—NOS3—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000595	0.00118	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—DAO—amyotrophic lateral sclerosis	0.000594	0.00118	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	0.000576	0.00114	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000559	0.00111	CbGpPWpGaD
L-Arginine—ASL—Metabolism—APOE—amyotrophic lateral sclerosis	0.000555	0.0011	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000548	0.00108	CbGpPWpGaD
L-Arginine—NOS3—Disease—PLB1—amyotrophic lateral sclerosis	0.000538	0.00106	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000536	0.00106	CbGpPWpGaD
L-Arginine—NOS3—Disease—VCP—amyotrophic lateral sclerosis	0.00048	0.000949	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000464	0.000917	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—APOE—amyotrophic lateral sclerosis	0.00046	0.00091	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000451	0.000891	CbGpPWpGaD
L-Arginine—NOS2—Disease—CST3—amyotrophic lateral sclerosis	0.000443	0.000877	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000422	0.000834	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000416	0.000823	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSR—amyotrophic lateral sclerosis	0.000416	0.000823	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000416	0.000823	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000387	0.000766	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.00038	0.000752	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000377	0.000745	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000376	0.000744	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000364	0.000721	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000354	0.000701	CbGpPWpGaD
L-Arginine—NOS3—Disease—CST3—amyotrophic lateral sclerosis	0.000344	0.000681	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000341	0.000676	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000336	0.000664	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000325	0.000643	CbGpPWpGaD
L-Arginine—NOS2—Disease—CASP9—amyotrophic lateral sclerosis	0.000322	0.000638	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000319	0.000631	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000315	0.000623	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000289	0.000571	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000286	0.000565	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000283	0.000559	CbGpPWpGaD
L-Arginine—NOS2—Disease—ERBB4—amyotrophic lateral sclerosis	0.000276	0.000546	CbGpPWpGaD
L-Arginine—NOS3—Disease—CASP9—amyotrophic lateral sclerosis	0.00025	0.000495	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000238	0.000471	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000218	0.000432	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERBB4—amyotrophic lateral sclerosis	0.000214	0.000424	CbGpPWpGaD
L-Arginine—NOS2—Disease—APOE—amyotrophic lateral sclerosis	0.000213	0.000422	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000196	0.000388	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000185	0.000365	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000184	0.000364	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000184	0.000363	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—amyotrophic lateral sclerosis	0.00018	0.000356	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000175	0.000347	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000169	0.000334	CbGpPWpGaD
L-Arginine—NOS3—Disease—APOE—amyotrophic lateral sclerosis	0.000166	0.000328	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.00015	0.000297	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTGS2—amyotrophic lateral sclerosis	0.000146	0.000289	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000141	0.000279	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—amyotrophic lateral sclerosis	0.00014	0.000276	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—APOE—amyotrophic lateral sclerosis	0.000139	0.000275	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000125	0.000247	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000116	0.00023	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTGS2—amyotrophic lateral sclerosis	0.000114	0.000225	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.59e-05	0.00019	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.51e-05	0.000188	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.38e-05	0.000146	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.97e-05	0.000138	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.26e-05	0.000124	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.73e-05	9.36e-05	CbGpPWpGaD
